Pacer Advisors Inc. Has $885,000 Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Pacer Advisors Inc. lifted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 56.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,803 shares of the company’s stock after buying an additional 4,982 shares during the quarter. Pacer Advisors Inc.’s holdings in Henry Schein were worth $885,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Summit Securities Group LLC bought a new position in Henry Schein in the 2nd quarter worth $31,000. Beach Investment Counsel Inc. PA acquired a new position in shares of Henry Schein during the 2nd quarter worth about $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the period. Mather Group LLC. grew its holdings in Henry Schein by 16.8% in the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after buying an additional 216 shares during the last quarter. Finally, Palisade Asset Management LLC bought a new position in Henry Schein in the 1st quarter worth approximately $113,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Price Performance

Henry Schein stock opened at $73.22 on Friday. The business has a 50 day simple moving average of $70.10 and a 200 day simple moving average of $70.22. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The company has a market capitalization of $9.38 billion, a PE ratio of 24.74, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same period last year, the business earned $1.31 earnings per share. The business’s revenue was up .0% on a year-over-year basis. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on HSIC shares. Evercore ISI lowered their price objective on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research note on Wednesday, August 7th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Piper Sandler reiterated an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. JPMorgan Chase & Co. lowered their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Finally, Robert W. Baird reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $77.10.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.